Standard Form Name: TAK-875
Other Names:
1000413-72-8
3-Benzofuranacetic acid, 6-[[2',6'-diMethyl-4'-[3-(Methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]Methoxy]-2,3-dihydro-, (3S)-
(3S)-6-[[2',6'-Dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]methoxy]-2,3-dihydro-3-benzofuranacetic acid
[(3s)-6-({2',6'-Dimethyl-4'-[3-(Methylsulfonyl)propoxy]biphenyl-3-Yl}methoxy)-2,3-Dihydro-1-Benzofuran-3-Yl]acetic Acid
[(3S)-6-([2',6'-DIMETHYL-4'-[3-(METHYLSULFONYL)PROPOXY]BIPHENYL-3-YL]METHOXY)-2,3-DIHYDRO-1-BENZOFURAN-3-YL]ACETIC ACID
[(3S)-6-({3-[4-(3-methanesulfonylpropoxy)-2,6-dimethylphenyl]phenyl}methoxy)-2,3-dihydro-1-benzofuran-3-yl]acetic acid
((3S)-6-((3-(4-(3-Methanesulfonylpropoxy)-2,6-dimethylphenyl]phenyl}methoxy)-2,3-dihydro-1-benzofuran-3-yl)acetic acid
4phu
A8339
AB0033816
ABP000968
AC-25651
AK170559
AKOS025289552
AOB2992
AT-35664
BCP02430
BDBM50386790
BZCALJIHZVNMGJ-HSZRJFAPSA-N
C29H32O7S
cc-64
CHEMBL1829174
CS-0282
D0V1WQ
DB12491
EX-A203
Fasiglifam
Fasiglifam (INN)
Fasiglifam [USAN:INN]
GLP1W4JXAH
GTPL6484
HY-10480
J-501277
KB-80796
KS-00001CRE
MolPort-023-293-501
NCGC00346669-01
PB24359
PubChem24441
QCR-231
RL00005
RL00413
(S)-2-(6-((2',6'-Dimethyl-4'-(3-(methylsulfonyl)propoxy)-[1,1'-biphenyl]-3-yl)methoxy)-2,3-dihydrobenzofuran-3-yl)acetic acid
SC-86271
SCHEMBL204652
TAK 875
TAK875
TAK-875(Fasiglifam)
UNII-GLP1W4JXAH
ZINC68208039
IUPAC name:
2-[(3S)-6-[[3-[2,6-dimethyl-4-(3-methylsulfonylpropoxy)phenyl]phenyl]methoxy]-2,3-dihydro-1-benzofuran-3-yl]acetic acid
PUBCHEM:
24857286
InChIKey:
BZCALJIHZVNMGJ-HSZRJFAPSA-M
InChI:
1S/C29H32O7S/c1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21(14-22)17-35-24-8-9-26-23(15-28(30)31)18-36-27(26)16-24/h4,6-9,12-14,16,23H,5,10-11,15,17-18H2,1-3H3,(H,30,31)/t23-/m1/s1
Image of the Standard Form:
Corresponding Specific State(s)
| Specific State ID: 5054 | Specific State ID: 5055 |
| |
 |
